Clinical trial · Interventional
Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors
NCT03661840CI-TRIAL-00087125completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acceptance and Commitment Therapy | Behavioral | — | UNRESOLVED |
| Treatment as Usual | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acceptance and Commitment Therapy
- description
- Participants will receive both the ACT intervention and medication management that is given as usual treatment.
- interventionNames
- Behavioral: Acceptance and Commitment Therapy
- type
- ACTIVE_COMPARATOR
- label
- Treatment as Usual
- description
- Treatment as usual will include ongoing provision of usual treatment options for pain management.
- interventionNames
- Other: Treatment as Usual
Primary outcomes (2)
- measure
- The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact]
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: 1. Provision to sign and date the consent form 2. Stated willingness to comply with all study procedures and be available for the duration of the study 3. Be a male or female aged 18-100 4. Have pathology confirmed diagnosis of a solid tumor cancer 5. Be three or more months out from active cancer treatment (surgery, chemotherapy, and/or radiation) 6. Endorses experiencing pain for three or more months prior to eligibility screening 7. Indicates moderate to severe difficulties with pain interference as related to their cancer experience, with a score of 4 or higher on the pain interference item from the Chronic Pain Grading Questionnaire 8. Shows no evidence of cancer disease (NED) or with stable, chronic disease under "watchful waiting" 9. Fluent in English 10. Psychiatric stability as assessed by chart review and study personnel (e.g., not exhibiting symptoms consistent with diagnoses of serious mental illness such as active psychosis or mania) Exclusion Criteria: 1. Having pain that can be solely attributed to a diagnosis outside of their cancer experience 2. Presenting with barriers to group participation (e.g., social anxiety) or when group-based provision of care would impede participant's treatment or that of other group members 3. Patients with a diagnosis of malignant neoplasm of the brain (ICD-10 C71) or malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (ICD-10 C72).
References
Publications (0)
Data not yet available
No reference posted for this study.